A carregar...
Oral Supplementation of Sodium Butyrate Attenuates the Progression of Non-Alcoholic Steatohepatitis
Sodium butyrate (SoB) supplementation has been suggested to attenuate the development of non-alcoholic fatty liver disease (NAFLD). Here, we determined the therapeutic potential of SoB on NAFLD progression and molecular mechanism involved. Eight-week old C57BL/6J mice were pair-fed a fat-, fructose-...
Na minha lista:
| Publicado no: | Nutrients |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
MDPI
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7231312/ https://ncbi.nlm.nih.gov/pubmed/32235497 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/nu12040951 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|